UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

British journal of cancer, 2013-03, Vol.108 (5), p.1052-1060

2013

Volltextzugriff (PDF)

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Annals of oncology, 2017-11, Vol.28 (11), p.2882-2887

2017

Volltextzugriff (PDF)

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials

Annals of oncology, 2015-12, Vol.26 (12), p.2450-2456

2015

Volltextzugriff (PDF)

Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib

Annals of oncology, 2017-08, Vol.28 (8), p.2021-2024

2017

Volltextzugriff (PDF)

Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition

Biochemical Society transactions, 2005-08, Vol.33 (Pt 4), p.689-693

2005

Volltextzugriff (PDF)

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

The pharmacogenomics journal, 2015-02, Vol.15 (1), p.69-76

2015

Volltextzugriff (PDF)

Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility

Cancer cell, 2004-08, Vol.6 (2), p.139-150

2004

Volltextzugriff (PDF)

An Msh2 point mutation uncouples DNA mismatch repair and apoptosis

Cancer research (Chicago, Ill.), 2004-01, Vol.64 (2), p.517-522

2004

Volltextzugriff (PDF)

Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification

The Journal of experimental medicine, 2004-07, Vol.200 (1), p.47-59

2004

Volltextzugriff (PDF)

Reply concerning KIAA0027 (WKL1, MLC1) and psychosis: white matters

Molecular psychiatry, 2002-12, Vol.7 (10), p.1037-1038

2002

Volltextzugriff (PDF)

p53 and c-Jun Functionally Synergize in the Regulation of the DNA Repair Gene hMSH2 in Response to UV

The Journal of biological chemistry, 2000-12, Vol.275 (48), p.37469-37473

2000

Volltextzugriff (PDF)

Isolation and characterization of the human mismatch repair gene hMSH2 promoter region

Human genetics, 1996, Vol.97 (1), p.114-116

1996

Volltextzugriff (PDF)

A putative Sec23 homologue of Plasmodium falciparum is located in Maurer’s clefts

Molecular and biochemical parasitology, 2003-07, Vol.129 (2), p.209-213

2003

Volltextzugriff (PDF)

Lack of ultraviolet-light inducibility of the medakafish (Oryzias latipes) tumor suppressor gene p53

Gene, 2001-02, Vol.264 (2), p.197-203

2001

Volltextzugriff (PDF)

Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2

Biochemical and biophysical research communications, 1996-04, Vol.221 (3), p.722-728

1996

Volltextzugriff (PDF)

Cephalosporins and Metronidazole as Risk Factors for ESBL-Producing Organisms

International journal of current research and review, 2019-09, Vol.11 (18), p.6-11

2019

Volltextzugriff (PDF)

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Annals of oncology, 2017-11, Vol.28 (11), p.2882

2017

Volltextzugriff (PDF)

Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies

Clinical cancer research, 2013-07, Vol.19 (13), p.3681-3692

2013

Volltextzugriff (PDF)

Virtual Reality in Health and Rehabilitation

1, 2021

Volltextzugriff (PDF)

Biomarkers of treatment benefit in a randomized phase II study of bevacizumab in combination with carboplatin and paclitaxel in metastatic melanoma patients (BEAM)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10563-10563

2010

Volltextzugriff (PDF)

Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal, non-small cell lung, and renal cell cancers: Analysis of phase III studies

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10519-10519

2010

Volltextzugriff (PDF)

Bevacizumab changes in patients with naïve, stage II-III breast cancer assessed by 18F-fluoromisonidazole and 18F-fluorotymidine PET-CT

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2529-2529

2011

Volltextzugriff (PDF)

Integrative and multidisciplinary clinical trial using imaging, molecular, and dynamic biomarkers to predict bevacizumab plus chemotherapy response in breast cancer

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS153-TPS153

2011

Volltextzugriff (PDF)

Everyday Technologies in Healthcare

1st edition., 2020

Volltextzugriff (PDF)

Disposition of cyromazine in plants under environmental conditions

Journal of agricultural and food chemistry, 1990-03, Vol.38 (3), p.860-864

1990

Volltextzugriff (PDF)

1 – 25 von 7.809

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.768)
Mit Volltextzugriff
(6.320)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.857)
Life Sciences & Biomedicine
(2.390)
Humans
(1.972)
Male
(1.140)
Female
(1.091)
Physical Sciences
(927)
Biological And Medical Sciences
(872)
Technology
(779)
Animals
(667)
Adult
(663)
Medical Sciences
(549)
Middle Aged
(497)
Physics
(470)
Fundamental And Applied Biological Sciences. Psychology
(421)
Engineering
(415)
Chemistry
(391)
Exact Sciences And Technology
(362)
Genetics & Heredity
(344)
Aged
(337)
Social Sciences
(316)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.608)
IngentaConnect
(2.591)
EZB Electronic Journals Library
(2.276)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.648)
NUS Single-Journal Subscriptions
(1.251)
ScienceDirect
(1.241)
Wiley Blackwell Single Titles
(1.073)
IngentaConnect Journals
(829)
Ebook Central Perpetual and DDA
(797)
Wiley Online Library
(786)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(727)
eBooks on EBSCOhost
(632)
SpringerLink
(532)
JSTOR
(382)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(353)
IEEE Xplore
(278)
Nature_系列刊
(264)
Oxford journals
(250)
Taylor & Francis
(196)
Taylor & Francis eBooks A-Z
(192)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Angewandte Chemie
(161)
Angewandte Chemie International Edition
(106)
Emotion
(96)
Chimères
(82)
Chemischer Informationsdienst
(62)
Chemische Berichte
(61)
Cheminform
(53)
Annals Of The Rheumatic Diseases
(46)
Proceedings Of The National Academy Of Sciences - Pnas
(46)
Nature Genetics
(45)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(37)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials

Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib

Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility

An Msh2 point mutation uncouples DNA mismatch repair and apoptosis

Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification

Reply concerning KIAA0027 (WKL1, MLC1) and psychosis: white matters

p53 and c-Jun Functionally Synergize in the Regulation of the DNA Repair Gene hMSH2 in Response to UV

Isolation and characterization of the human mismatch repair gene hMSH2 promoter region

A putative Sec23 homologue of Plasmodium falciparum is located in Maurer’s clefts

Lack of ultraviolet-light inducibility of the medakafish (Oryzias latipes) tumor suppressor gene p53

Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2

Cephalosporins and Metronidazole as Risk Factors for ESBL-Producing Organisms

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies

Virtual Reality in Health and Rehabilitation

Biomarkers of treatment benefit in a randomized phase II study of bevacizumab in combination with carboplatin and paclitaxel in metastatic melanoma patients (BEAM)

Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal, non-small cell lung, and renal cell cancers: Analysis of phase III studies

Bevacizumab changes in patients with naïve, stage II-III breast cancer assessed by 18F-fluoromisonidazole and 18F-fluorotymidine PET-CT

Integrative and multidisciplinary clinical trial using imaging, molecular, and dynamic biomarkers to predict bevacizumab plus chemotherapy response in breast cancer

Everyday Technologies in Healthcare

Disposition of cyromazine in plants under environmental conditions

Suchergebnisse filtern